The Dangers of No CFO Lessons from Theranos

In late 2006, Henry Mosley, the Chief Financial Officer of a rising startup called Theranos, walked into Elizabeth Holmes’s office to discuss a troubling discovery. He'd learned that the company’s celebrated blood-testing demonstrations were faked using pre-recorded results. When he suggested they stop misleading investors, Holmes’s demeanor shifted from cheerful to hostile, and she fired him on the spot for not being a "team player."

This moment marked a turning point where the company abandoned traditional corporate finance oversight to protect a growing web of lies. For the next decade, Theranos operated without a legitimate CFO, allowing the leadership to present fraudulent projections to the world's most sophisticated investors. Without a financial gatekeeper, the company’s internal reality and its public persona drifted miles apart.

Transparency in Finance Defined

In John Carreyrou’s "Bad Blood," transparency in finance is shown as the essential bridge between a company’s operations and its stakeholders. It's the practice of providing an honest, verified account of a company’s financial health and performance. This isn't just about filing taxes; it's about ensuring that the numbers presented to the board and investors reflect actual bank balances and realistic revenue streams.

In the startup world, founders often use "hockey-stick" forecasts to sell a vision of future growth. However, Carreyrou illustrates that when these projections aren't grounded in any technical or financial reality, they cross the line into fraud. Transparency serves as the primary defense against the "fake it till you make it" culture becoming a criminal enterprise.

Why Henry Mosley Was Fired for Being Honest

Henry Mosley was a veteran of the Silicon Valley scene, having run finance departments for four different tech companies and taking two of them public. He understood that while startups are aspirational, they must remain tethered to the truth. When he discovered that a Novartis demo was saved by a "fake result" beamed from California to Switzerland, he knew the company had crossed an ethical red line.

His immediate termination sent a clear message to the rest of the organization: loyalty to the founder’s narrative was more important than financial integrity. By removing the one person authorized to look under the hood, Holmes ensured that no one would challenge her increasingly bold claims. This lack of an independent voice meant that for years, the company’s spending and revenue claims went entirely unchecked.

Essential Corporate Finance Oversight in Growth Stages

Corporate finance oversight requires a dedicated leader who reports not just to the CEO, but also to the board of directors. In a healthy company, the finance lead acts as a check on the CEO’s optimism. They ensure that every dollar claimed on a pitch deck is backed by a signed contract or a verified transaction.

Theranos replaced this oversight with a culture of compartmentalization. Different departments were forbidden from speaking to each other, and the "corporate controller" was a mid-level employee who didn't have the authority of a CFO. According to a 2018 McKinsey report, companies with strong financial governance are 20% more likely to survive market downturns than those without.

Consequences of Operating Without a Chief Financial Officer

The lack of a Chief Financial Officer allowed Theranos to present two sets of books. Internal documents from the corporate controller showed modest, struggling revenue. Meanwhile, Sunny Balwani and Elizabeth Holmes presented investors with spreadsheets that were almost entirely fabricated.

For instance, internal projections for 2015 estimated revenues of just $134 million. However, the numbers shown to the hedge fund Partner Fund Management projected a staggering $1.68 billion in revenue for that same year. Without a CFO to sign off on these figures, Balwani was free to invent numbers that made the company look like a $9 billion unicorn.

Reality Versus the Pitch Deck

The most egregious example of this oversight failure was the $100 million "innovation fee" negotiated with Walgreens. The retailer’s executives were so caught up in the "fear of missing out" that they failed to conduct deep financial due diligence. They relied on a two-page summary from Johns Hopkins that explicitly stated it was not an endorsement of the technology.

Theranos also claimed its devices were in the back of Humvees in the Middle East. This was a complete fabrication used to lure investors like the Lucas Venture Group. A CFO would have been required to show the actual government contracts, which didn't exist, as the military had never officially deployed the technology for patient use.

Three Ways to Protect Your Business From Fraud

1. Hire an independent finance lead early. This person must have the authority to challenge the CEO and a direct reporting line to the board’s audit committee. They should be a veteran who understands that their first duty is to the company’s survival, not the founder’s ego.

2. Require annual third-party audits. Never rely on internal spreadsheets for major investment rounds or partnership agreements. A reputable accounting firm must verify that revenue is recognized according to standard accounting principles and that bank statements match the books.

3. Tie projections to historical data. While startups are future-oriented, every forecast must be a logical extension of current performance. If your revenue projections are 12 times higher than your internal reality, like they were at Theranos, you're no longer forecasting—you're committing fraud.

When Founders Avoid the Numbers

Critics often argue that strict financial oversight can stifle the creativity and speed of a young startup. They believe that "move fast and break things" requires a certain level of financial flexibility. Silicon Valley culture sometimes treats the CFO as a "no-man" who prevents the founder from taking the big risks necessary for a breakthrough.

While speed is important, the Theranos case proves that the absence of oversight doesn't lead to innovation—it leads to institutionalized deception. The company spent hundreds of millions of dollars on a technology that never worked. In the end, the lack of a CFO didn't help Theranos grow; it simply made its eventual collapse much more catastrophic.

Strong corporate finance oversight isn't about slowing down; it's about making sure the bus you're driving actually has an engine. Theranos claimed to be a unicorn with $1.5 billion in potential revenue, but it was really just a collection of expensive offices and a culture of fear. Audit your own revenue projections against your actual bank receipts tonight to ensure you aren't falling into the same trap.